(Q36484951)

English

Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

object named as

Kaoru Mogushi

3

0 references

author name string

Abudureheman Mayinuer

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Mahmut Yasen

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Gulanbar Obulhasim

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Maimaiti Xieraili

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Arihiro Aihara

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Shinji Tanaka

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hiroshi Mizushima

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hiroshi Tanaka

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Shigeki Arii

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

13 October 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

305-317

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Regulation of cell adhesion by protein-tyrosine phosphatases. I. Cell-matrix adhesion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Opportunities for targeted therapies in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

PRL-3 phosphatase is implicated in ovarian cancer growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Global cancer statistics, 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

PRL-3 expression in metastatic cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

PRL-3 and PRL-1 promote cell migration, invasion, and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

A phosphatase associated with metastasis of colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Rho GTPases control polarity, protrusion, and adhesion during cell movement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

30 September 2017

Expression of phosphatase of regenerating liver-3 in squamous cell carcinoma of the cervix.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3528959

21 September 2018

Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: current surgical management

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1245/S10434-012-2395-2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36484951&oldid=2198954719"